| Stock Price Performance - 12 Largest Positive Opening Gaps | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day of Event |
After Event Date (Not Including Day of Selected Event) |
||||||||||||||||
| Date | Note | Day-Of Move | Opening Gap | % Open-to-High | % Open-to-Low | Drift Open-to-Close | 1 Day | 2 Days | 3 Days | 1 Week | 2 Weeks | ||||||
| 1-Jul-2025 |
Press Release Vivos Therapeutics Receives Medicare Approval for VidaSleep Oral Appliance (1-Jul-2025, 8:30 AM Globe Newswire) |
+22.5% | |||||||||||||||
| 26-Jun-2025 |
Press Release New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children (26-Jun-2025, 8:30 AM Globe Newswire) |
+10.5% | |||||||||||||||
| 18-Sep-2024 |
Press Releases Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring (18-Sep-2024, 7:00 AM Globe Newswire) FDA Approval Sends Shares of this Healthcare Company Higher (18-Sep-2024, 6:18 PM Yolowire) |
+47.5% | |||||||||||||||
| 6-Feb-2024 |
Press Release Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities (6-Feb-2024, 7:30 AM Globe Newswire) |
-4.9% | |||||||||||||||
| 26-Jan-2024 | +4.5% | ||||||||||||||||
| 29-Nov-2023 |
Press Release Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral Device Treatment of Severe Obstructive Sleep Apnea (29-Nov-2023, 7:30 AM Globe Newswire) |
+833.9% | |||||||||||||||
| 24-Oct-2023 |
Press Release Vivos Therapeutics Signs Nationwide Distribution Agreement with Lincare (24-Oct-2023, 7:30 AM Globe Newswire) |
-5.8% | |||||||||||||||
| 5-Oct-2023 |
Press Releases Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark Clear Aligners to Its National Network of Providers (4-Oct-2023, 7:30 AM Globe Newswire) Vivos Therapeutics Announces Strategic Collaboration in the Middle East-North Africa Region to Support International Expansion (5-Oct-2023, 7:30 AM Globe Newswire) |
+6.9% | |||||||||||||||
| 4-Oct-2023 |
Press Release Vivos Therapeutics Executes Strategic Agreements with Ormco and On Demand Orthodontist To Provide Spark Clear Aligners to Its National Network of Providers (4-Oct-2023, 7:30 AM Globe Newswire) |
+64.6% | |||||||||||||||
| 26-Sep-2023 | -0.5% | ||||||||||||||||
| 8-Aug-2023 | +53.2% | ||||||||||||||||
| 27-Apr-2023 | +3.2% | ||||||||||||||||
| Simple Average Returns - 12 Largest Positive Opening Gaps | |||||||||||||||||
| Avg Return | |||||||||||||||||
| Positive Occurrences | |||||||||||||||||
| Negative Occurrences | |||||||||||||||||
| Absolute Average Returns - 12 Largest Positive Opening Gaps | |||||||||||||||||
| Abs Avg Return | |||||||||||||||||
| Max Abs Return | |||||||||||||||||
| Min Abs Return | |||||||||||||||||
| Median, Minimum, and Maximum Returns - 12 Largest Positive Opening Gaps | |||||||||||||||||
| Median Return | |||||||||||||||||
| Max Positive Return | |||||||||||||||||
| Max Negative Return | |||||||||||||||||